Another strategist chops his S&P 500 target — but for a different reason than the Goldman Sachs reduction
The reduction by Ed Yardeni, president and chief investment strategist of Yardeni Research, is notable for a few reasons, one ...
Why this Wall Street strategist says investors should stick with U.S. stocks despite recession fears
Oppenheimer’s John Stoltzfus, the most bullish strategist on Wall Street with a target for the S&P 500 to hit 7,100 by the ...
Goldman's Oppenheimer warns U.S. stock market may continue to underperform
Goldman Sachs analysts are cautioning that “confidence in the US growth story is moderating” and the U.S. stock market may continue to lag behind other global markets.
An S&P correction exceeding 10% will inflict pain on global stocks, Goldman says
Global equities are likely to be yanked into the red should the S&P 500 (SP500) undergo a correction deeper than 10%, ...
Pensions & Investments1d
UPS investment staff moved to Goldman Sachs Asset Management. Here's how it went.
Ernie Caballero didn’t know how good working for a giant money manager could be. In September, the 35 year UPS veteran and ...
Wall Street's Nightmare Scenario: Why a 10% S&P 500 Drop Could Wipe Out Global Markets
Goldman Sachs is waving a red flag for global equities as the S&P 500 edges closer to a full-blown correction, now down more ...
Reuters11d
Goldman Sachs may cut more than 1,300 employees in annual review, source says
NEW YORK, March 4 (Reuters) - Goldman Sachs (GS.N), opens new tab plans to trim its staffing by 3% to 5% in an annual ...
Tarsus Pharmaceuticals 2.809M share Spot Secondary priced at $44.50
The deal size was increased to $125M in common stock from $100M in common stock. Goldman Sachs, BofA, Barclays and Oppenheimer acted as joint ...